Literature DB >> 25188280

High prevalence of hand- and wrist-related symptoms, impairments, activity limitations and participation restrictions in children with juvenile idiopathic arthritis.

Agnes F Hoeksma1, Marion A J van Rossum, Wilma G W Zinger, Koert M Dolman, Joost Dekker, Leo D Roorda.   

Abstract

OBJECTIVE: To determine the prevalence of hand- and wrist-related symptoms and impairments, with resulting activity limitations and participation restrictions in children being treated for juvenile idiopathic arthritis. DESIGN AND PATIENTS: Cohort study of children, diagnosed in our hospitals between 2003 and 2008 with juvenile idiopathic arthritis, who received standard treatment with regular follow-ups in the same institutions. Patients were asked about hand and wrist symptoms, and underwent a standardized physical examination. For activity limitations, they were asked to complete the Dutch version of the Childhood Health Assessment Questionnaire (CHAQ). Concerning participation restrictions, children were asked about any hand- and/or wrist-related difficulties during daily activities.
RESULTS: Of all 152 eligible patients, 121 (80%) participated in the study; 34 boys and 87 girls, mean age 13.7 years (standard deviation (SD) 4.2), mean disease duration 2.6 years (SD 1.4), mean Juvenile Arthritis Disease Activity Score in 71 joints (JADAS-71) score 8 (SD 8), indicating low disease activity. Of these 121, 84 (69%) had at least 1 symptom and 40% had at least 1 impairment. The median CHAQ-total score was 0.5 (mean 0.75 (SD 0.77)), indicating mild-to-moderate activity limitations; and 54% reported having hand- and/or wrist-related problems at school.
CONCLUSION: Despite low disease activity, many children appeared to have hand- and/or wrist-related symptoms and impairments, with resulting moderate to severe levels of activity limitations and participation restrictions at school.

Entities:  

Mesh:

Year:  2014        PMID: 25188280     DOI: 10.2340/16501977-1879

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  6 in total

1.  Reference values of intrinsic muscle strength of the hand of adolescents and young adults.

Authors:  Chao-Ying Chen; Corey W McGee; Tonya L Rich; Cecília N Prudente; Bernadette T Gillick
Journal:  J Hand Ther       Date:  2017-08-12       Impact factor: 1.950

2.  Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers.

Authors:  Esi M Morgan; Constance A Mara; Bin Huang; Kimberly Barnett; Adam C Carle; Jennifer E Farrell; Karon F Cook
Journal:  Qual Life Res       Date:  2016-12-02       Impact factor: 4.147

3.  Validity and reliability of "Shriners Hospital for Children Upper Extremity Evaluation" in children with rheumatic diseases.

Authors:  Gokce Leblebici; Ugur Ovacik; Feray Gungor; Jon Robert Davids; Ela Tarakci; Ozgur Kasapcopur
Journal:  Clin Rheumatol       Date:  2021-08-05       Impact factor: 2.980

4.  Patient-Reported Barriers at School for Children with Juvenile Idiopathic Arthritis.

Authors:  Kelsey Chomistek; Nicole Johnson; Rebeka Stevenson; Nadia Luca; Paivi Miettunen; Susanne M Benseler; Dwaraka Veeramreddy; Heinrike Schmeling
Journal:  ACR Open Rheumatol       Date:  2019-05-09

5.  Marfan syndrome in adolescence: adolescents' perspectives on (physical) functioning, disability, contextual factors and support needs.

Authors:  Jessica Warnink-Kavelaars; Anita Beelen; Tine M H J Goedhart; Lisanne E de Koning; Frans Nollet; Mattijs W Alsem; Leonie A Menke; Raoul H H Engelbert
Journal:  Eur J Pediatr       Date:  2019-10-16       Impact factor: 3.183

6.  Determining correlations between hand grip strength and anthropometric measurements in preschool children.

Authors:  Amira G Mahmoud; Eman I Elhadidy; Mohamed S Hamza; Nanees E Mohamed
Journal:  J Taibah Univ Med Sci       Date:  2020-02-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.